ID Neo Jurkat AC CVCL_U621 DR ATCC; CRL-2898 DR cancercelllines; CVCL_U621 DR Wikidata; Q54930401 RX PubMed=10567572; CC Population: Caucasian. CC Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line). CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. CC Cell type: T-cell; CL=CL_0000084. ST Source(s): ATCC=CRL-2898 ST Amelogenin: X,Y ST CSF1PO: 11,12 ST D13S317: 8,12 ST D16S539: 11 ST D18S51: 13,21 ST D19S433: 14,15.2 ST D21S11: 31.2,33.2 ST D2S1338: 19,23 ST D3S1358: 15,17 ST D5S818: 9 ST D7S820: 8,12 ST D8S1179: 13,14 ST FGA: 20,21 ST Penta D: 11,13 ST Penta E: 10,12 ST TH01: 6,9.3 ST TPOX: 8,10 ST vWA: 18 DI NCIt; C7953; Childhood T acute lymphoblastic leukemia DI ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_0065 ! Jurkat SX Male AG 14Y CA Cancer cell line DT Created: 16-04-14; Last updated: 19-12-24; Version: 20 // RX PubMed=10567572; DOI=10.1128/mcb.19.12.8469; PMCID=PMC84954; RA Yamamoto K., Ichijo H., Korsmeyer S.J.; RT "BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal RT protein kinase pathway normally activated at G(2)/M."; RL Mol. Cell. Biol. 19:8469-8478(1999). //